HealthTech

League Unveils AI-Powered Platform Enhancements for Car...

What You Should Know:  – League, a healthcare consumer experience (CX) platform ...

Datavant Launches Clinical Insights Platform to Empower...

What You Should Know:  – Datavant, a health data platform company announced the ...

Walgreens to go private in $10B deal

Walgreens is entering a new chapter as it agrees to sell itself to a private equ...

Debunked Episode 13: Will the Real AI Please Stand Up?

The latest episode of Debunked, with MedCity News Editor in Chief Arundhati Parm...

Key Insights & Top Takeaways from HIMSS25 Day 3

This week, Healthcare IT Today is attending HIMSS25 in Las Vegas! For those not ...

Moderna stands by its Covid vaccine patents after PTAB ...

Moderna says its long-running patent dispute with Pfizer and BioNTech isn't over...

Teladoc Health, Eli Lilly Partner to Add GLP-1 Self-Pay...

What You Should Know:  – Teladoc Health, the global leader in virtual care annou...

MSK to Deploy Abridge’s AI Oncology Clinical Documentation

What You Should Know: – Abridge announced that its AI platform to support clinic...

Rune Labs Launches AI and Personalized Coaching Care Ma...

What You Should Know: –  Rune Labs, the leader in precision medicine for Parkins...

Elsevier Health Launches HESI Clinical Practice Readine...

What You Should Know: – Elsevier Health, a global leader in medical information ...

Healthcare is bullish on AI

It’s only been about two years since healthcare really started adopting generati...

Corrected: Merck KGaA’s mixed Phase 2 lupus results; Zy...

Plus, news about Tris Pharma and ARS Pharmaceuticals: Merck KGaA’s lupus dru...

CordenPharma’s €100M investment top-up; Cytiva to lay o...

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...

Longtime biotech investor Frazier Life Sciences is rais...

Frazier Life Sciences, a decades-old biotech investor, is raising another heap o...

Novo Nordisk’s rare disease ‘company within a company’ ...

Novo Nordisk is known for making therapies for some of the world’s most prevalen...

Merck KGaA’s lupus drug fails in Phase 2; Zymeworks pau...

Plus, news about Tris Pharma and ARS Pharmaceuticals: Merck KGaA’s lupus dru...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.